Related references
Note: Only part of the references are listed.Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999-2004
Bernard M. Y. Cheung et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Vitamin D deficiency and risk of cardiovascular disease
Thomas J. Wang et al.
CIRCULATION (2008)
Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese
Bernard M. Y. Cheung et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcification
K. A. Lomashvili et al.
KIDNEY INTERNATIONAL (2008)
High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death
Margaret J. Blayney et al.
KIDNEY INTERNATIONAL (2008)
Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification
Sonoko Narisawa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Hypoadiponectinemia as a predictor for the development of hypertension - A 5-year prospective study
Wing-Sun Chow et al.
HYPERTENSION (2007)
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
Giovanni Targher et al.
ATHEROSCLEROSIS (2007)
Risk factors for premature peripheral vascular disease: Results for the National Health and Nutritional Survey, 1999-2002
John S. Lane et al.
JOURNAL OF VASCULAR SURGERY (2006)
The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue
Aus T. Ali et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2006)
Justification for the use of statins in primary prevention: An intervention trial evaluating rosuvastatin (JUPITER) - Can C-reactive protein be used to target statin therapy in primary prevention?
S Mora et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Relation of inflammation to peripheral arterial disease in the National Health and Nutrition Examination Survey, 1999-2002
RP Wildman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Liver markers and development of the metabolic syndrome - The insulin resistance atherosclerosis study
AJG Hanley et al.
DIABETES (2005)
Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease
JD Vu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Alkaline phosphatase is involved in the control of adipogenesis in the murine preadipocyte cell line, 3T3-LI
AT Ali et al.
CLINICA CHIMICA ACTA (2005)
Vascular calcification - Mechanisms and clinical ramifications
M Abedin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease - The PRIME study
G Luc et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population - The Funagata study
M Daimon et al.
DIABETES CARE (2003)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)